[go: up one dir, main page]

AU2001276752A1 - Virus-like micrograins and process for producing the same - Google Patents

Virus-like micrograins and process for producing the same

Info

Publication number
AU2001276752A1
AU2001276752A1 AU2001276752A AU7675201A AU2001276752A1 AU 2001276752 A1 AU2001276752 A1 AU 2001276752A1 AU 2001276752 A AU2001276752 A AU 2001276752A AU 7675201 A AU7675201 A AU 7675201A AU 2001276752 A1 AU2001276752 A1 AU 2001276752A1
Authority
AU
Australia
Prior art keywords
micrograins
virus
producing
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276752A
Inventor
Yuko Morikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitasato Institute
Original Assignee
Kitasato Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitasato Institute filed Critical Kitasato Institute
Publication of AU2001276752A1 publication Critical patent/AU2001276752A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16023—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2001276752A 2000-08-08 2001-08-07 Virus-like micrograins and process for producing the same Abandoned AU2001276752A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000239903 2000-08-08
JP2000-239903 2000-08-08
PCT/JP2001/006791 WO2002012454A1 (en) 2000-08-08 2001-08-07 Virus-like micrograins and process for producing the same

Publications (1)

Publication Number Publication Date
AU2001276752A1 true AU2001276752A1 (en) 2002-02-18

Family

ID=18731360

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276752A Abandoned AU2001276752A1 (en) 2000-08-08 2001-08-07 Virus-like micrograins and process for producing the same

Country Status (5)

Country Link
US (1) US20040009193A1 (en)
EP (1) EP1310551A4 (en)
AU (1) AU2001276752A1 (en)
CA (1) CA2418091A1 (en)
WO (1) WO2002012454A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964196B2 (en) * 2004-05-25 2011-06-21 Chimeros, Inc. Self-assembling nanoparticle drug delivery system
US7951384B2 (en) * 2005-08-05 2011-05-31 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US9216212B2 (en) 2005-08-05 2015-12-22 University Of Massachusetts Virus-like particles as vaccines for paramyxovirus
US20070141352A1 (en) * 2005-12-15 2007-06-21 Calhoun Patricia H Cross-directional elastic films with machine direction stiffness
ES2334528B1 (en) * 2007-01-23 2011-01-24 Alberto Garcia Quintanilla PROCESS TO GENERATE IN VIVO DIVERSITY WITH DIAGNOSTIC, THERAPEUTIC OR VACCINE USE.
HUE058165T2 (en) * 2009-09-22 2022-07-28 Medicago Inc Process for the production of proteins of plant origin
WO2016168187A1 (en) * 2015-04-13 2016-10-20 The Regents Of The University Of Michigan Virus-like particles
CN107779458B (en) * 2016-08-29 2023-06-20 中国科学院上海巴斯德研究所 A virus-like particle of rabies virus expressed by yeast cells and its preparation method

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE162949T1 (en) * 1989-10-31 1998-02-15 Us Health DESIGN AND CONSTRUCTION OF NON-INFECTIOUS HUMAN RETROVIRUS MUTANTS DEFECTIVE IN GENOMIC RNA
US6100025A (en) * 1990-04-20 2000-08-08 Cold Spring Harbor Laboratory Cloning by complementation and related processes
US5912338A (en) * 1990-10-12 1999-06-15 Benjamin Rovinski Nucleic acids encoding self-assembled, non-infectious, non-replicating, immunogenic retrovirus-like particles comprising modified HIV genomes and chimeric envelope glycoproteins
GB9208218D0 (en) * 1992-04-14 1992-05-27 British Bio Technology Hybrid particles
KR0172970B1 (en) * 1992-06-17 1999-02-01 김영길 Chimeric proteins useful for an aids vaccine and the preparation thereof
US5891444A (en) * 1995-06-07 1999-04-06 Virus Research Institute, Inc. HIV-1 prophylactic composition and method
US5869287A (en) * 1996-07-12 1999-02-09 Wisconsin Alumni Research Foundation Method of producing particles containing nucleic acid sequences in yeast
US6602705B1 (en) * 1998-12-31 2003-08-05 Chiron Corporation Expression of HIV polypeptides and production of virus-like particles

Also Published As

Publication number Publication date
US20040009193A1 (en) 2004-01-15
CA2418091A1 (en) 2002-02-14
EP1310551A4 (en) 2004-09-22
WO2002012454A1 (en) 2002-02-14
EP1310551A1 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
AU4467801A (en) Chlamydospores and process for producing the same
AU2001274511A1 (en) Adsorbent, process for producing the same, and applications thereof
AU3226801A (en) Bulky sheet and process for producing the same
AU2001227573A1 (en) Ceramics and process for producing
AU2882201A (en) Sustained-release preparation and process for producing the same
AU2000263163A1 (en) Soft candies and process for producing the same
AU2001267831A1 (en) DDS compound and process for the preparation thereof
AU2001276752A1 (en) Virus-like micrograins and process for producing the same
AU2001248825A1 (en) Process for producing microsphere
AU2001234616A1 (en) Vaccine composition, process and methods
AU2002218440A1 (en) New process
AU2001288789A1 (en) Airbag and method for producing the same
AU2002227966A1 (en) Coniosetin and derivatives thereof, method for producing the same and use thereof
AU7456101A (en) Process for producing hexafluoroethane and use thereof
AU2001242750A1 (en) Novel protein, process for producing the same and use thereof
AU2002229149A1 (en) Process for producing hydrazinomonosaccharide derivatives and use thereof
AU2002218494A1 (en) Medicinal compositions and process for producing the same
AU2001267769A1 (en) Process
AU2001283030A1 (en) Process for making 3-hydroxyalkanenitriles and hydroxyaminoalkanes
AU2001284442A1 (en) Process for producing fluoroalkanol
AU2001294181A1 (en) Novel protein, process for producing the same and use thereof
AU2001227071A1 (en) Novel substance m-17a and process for producing the same
AU2000228300A1 (en) Novel substance fki-0076 and process for producing the same
AU2002216364A1 (en) Novel substance fki-1083 and process for producing the same